Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 17, 2017 - Issue 3
Submit an article Journal homepage
652
Views
23
CrossRef citations to date
0
Altmetric
Review

Antipsychotic drugs in Huntington’s disease

E. UntiDepartment of Clinical and Experimental Medicine-Neurology Unit, University of Pisa, Pisa, ItalyCorrespondence[email protected]
View further author information
,
S. MazzucchiDepartment of Clinical and Experimental Medicine-Neurology Unit, University of Pisa, Pisa, ItalyView further author information
,
G. PalermoDepartment of Clinical and Experimental Medicine-Neurology Unit, University of Pisa, Pisa, ItalyView further author information
,
U. BonuccelliDepartment of Clinical and Experimental Medicine-Neurology Unit, University of Pisa, Pisa, ItalyView further author information
&
R. CeravoloDepartment of Clinical and Experimental Medicine-Neurology Unit, University of Pisa, Pisa, ItalyView further author information
Pages 227-237 | Received 12 May 2016, Accepted 16 Aug 2016, Published online: 23 Aug 2016

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Isabella Berardelli, Massimo Pasquini, Antonella Conte, Matteo Bologna, Alfredo Berardelli & Giovanni Fabbrini. (2019) Treatment of psychiatric disturbances in common hyperkinetic movement disorders. Expert Review of Neurotherapeutics 19:1, pages 55-65.
Read now
H. Bashir & J. Jankovic. (2018) Treatment options for chorea. Expert Review of Neurotherapeutics 18:1, pages 51-63.
Read now

Articles from other publishers (21)

Andrew Jiang, Renee R. Handley, Klaus Lehnert & Russell G. Snell. (2023) From Pathogenesis to Therapeutics: A Review of 150 Years of Huntington’s Disease Research. International Journal of Molecular Sciences 24:16, pages 13021.
Crossref
Aishika Datta, Deepaneeta Sarmah, Harpreet Kaur, Antra Chaudhary, Namrata Vadak, Anupom Borah, Sudhir Shah, Xin Wang & Pallab Bhattacharya. (2022) Advancement in CRISPR/Cas9 Technology to Better Understand and Treat Neurological Disorders. Cellular and Molecular Neurobiology 43:3, pages 1019-1035.
Crossref
Daniele Urso, Veria Vacchiano, Giovanni Rizzo & Giancarlo Logroscino. 2023. Movement Disorders Emergencies. Movement Disorders Emergencies 49 84 .
Swapnali Vasant Birajdar, Manisha Mulchandani, Farhan Mazahir & Awesh K. Yadav. 2023. Nanomedicine-Based Approaches for the Treatment of Dementia. Nanomedicine-Based Approaches for the Treatment of Dementia 1 36 .
Chunyu Ma, Zhihan Zhou, Han Liu & David Koslicki. (2023) KGML-xDTD: a knowledge graph–based machine learning framework for drug treatment prediction and mechanism description. GigaScience 12.
Crossref
Mukta Gupta, Sanjana, Naresh Singh, Balbir Singh & Perwez Alam. (2022) Role of natural products in alleviation of Huntington's disease: An overview. South African Journal of Botany 151, pages 263-276.
Crossref
Hilda T. Maibach, Michael J. Brownstein, Steven M. Hersch, Karen E. Anderson, Debra E. Itzkowitz, Eve M. Damiano & Neal G. Simon. (2022) The Vasopressin 1a Receptor Antagonist SRX246 Reduces Aggressive Behavior in Huntington’s Disease. Journal of Personalized Medicine 12:10, pages 1561.
Crossref
Sukriti Vishwas, Monica Gulati, Rubiya Khursheed, K.R. Arya, Sachin Kumar Singh, Niraj Kumar Jha, Parteek Prasher, Deepak Kumar & Vijay Kumar. 2022. Drug Delivery Systems for Metabolic Disorders. Drug Delivery Systems for Metabolic Disorders 189 206 .
Yijing Bai, Long Niu, Song Li & Weidong Le. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 4271 4301 .
Sweta Shah, Marc Marie Dooms, Sofia Amaral-Garcia & Mariana Igoillo-Esteve. (2021) Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders. Frontiers in Pharmacology 12.
Crossref
David M. Taylor, Thomas R. E. Barnes & Allan H. Young. 2021. The Maudsley Prescribing Guidelines in Psychiatry. The Maudsley Prescribing Guidelines in Psychiatry 777 830 .
Shujun Chen, Tianyu Liang, Tao Xue, Shouru Xue & Qun Xue. (2021) Pridopidine for the Improvement of Motor Function in Patients With Huntington's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Neurology 12.
Crossref
Hervé Javelot, Mylène Meyer, Solène Frismand & Coraline Hingray. (2021) Benefit of long-acting paliperidone in Huntington’s disease: a case report. International Clinical Psychopharmacology 36:2, pages 101-103.
Crossref
Emily Sanrey, Valérie Macioce, Victoria Gonzalez, Laura Cif, Fabienne Cyprien, Emilie Chan Seng, Philippe Coubes & Gaetan Poulen. (2020) Does pallidal neuromodulation influence cognitive decline in Huntington’s disease?. Journal of Neurology 268:2, pages 613-622.
Crossref
Giovanni Palermo, Sonia Mazzucchi, Elisa Unti, Ubaldo Bonuccelli & Roberto Ceravolo. (2020) Tardive Syndrome Associated With Tetrabenazine in Huntington Disease. Journal of Clinical Psychopharmacology 40:6, pages 628-630.
Crossref
Nicholas E. Karagas, Natalia Pessoa Rocha & Erin Furr Stimming. (2020) Irritability in Huntington’s Disease. Journal of Huntington's Disease 9:2, pages 107-113.
Crossref
Yijing Bai, Long Niu, Song Li & Weidong Le. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 31 .
Elvina May-Yin Chu, Mari O’Neill, Debasish Das Purkayastha & Caroline Knight. (2019) Huntington’s disease: a forensic risk factor in women. Journal of Clinical Movement Disorders 6:1.
Crossref
Natalia P. Rocha, Benson Mwangi, Carlos A. Gutierrez Candano, Cristina Sampaio, Erin Furr Stimming & Antonio L. Teixeira. (2018) The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database. Frontiers in Neurology 9.
Crossref
Andrea E. CavannaAndrea E. Cavanna. 2018. Motion and Emotion. Motion and Emotion 93 99 .
Prashant Tibrewal, Tarun Bastiampillai, Rohan Dhillon, Rachel Cheng & H. Tanuje Fonseka. (2017) Use of zuclopenthixol in the treatment of aggression in Huntington’s disease. Asian Journal of Psychiatry.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.